BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China · Delayed Price · Currency is CNY 53.39
+1.49 (2.87%)
At close: Oct 24, 2025
SHA:688166 Market Cap
SHA:688166 has a market cap or net worth of 22.57 billion as of October 24, 2025. Its market cap has increased by 121.41% in one year.
Market Cap
22.57B
Enterprise Value
24.24B
Revenue
1.16B
Ranking
n/a
PE Ratio
225.53
Stock Price
53.39
Market Cap Chart
Since November 8, 2019, SHA:688166's market cap has increased from 12.55B to 22.57B, an increase of 79.84%. That is a compound annual growth rate of 10.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 22.57B | 77.05% |
| Dec 31, 2024 | 12.75B | -13.79% |
| Dec 29, 2023 | 14.79B | 55.07% |
| Dec 30, 2022 | 9.54B | -36.65% |
| Dec 31, 2021 | 15.05B | -19.85% |
| Dec 31, 2020 | 18.78B | 44.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 435.31B |
| WuXi AppTec | 306.37B |
| Shenzhen Mindray Bio-Medical Electronics | 267.94B |
| Sichuan Biokin Pharmaceutical | 145.45B |
| Shanghai United Imaging Healthcare | 116.57B |
| Aier Eye Hospital Group | 113.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 109.03B |
| Yunnan Baiyao Group Co.,Ltd | 100.56B |